Multiple sources are pointing to a new report that Merck paid Elsevier, a leading publisher, to produce several volumes of the Australasian Journal of Bone and Joint Medicine, which appeared to be a peer-reviewed journal, but was really little more than marketing material for the pharmaceutical company.
Merck and Elsevier Published Fake Journal
May 4, 2009
Share this post
2 Comments

Law Bytes
Episode 247: My Senate Appearance on the Bill That Could Lead to Canada-Wide Blocking of X, Reddit and ChatGPT
byMichael Geist

October 27, 2025
Michael Geist
October 20, 2025
Michael Geist
October 6, 2025
Michael Geist
September 22, 2025
Michael Geist
September 15, 2025
Michael Geist
Search Results placeholder
Recent Posts
The Law Bytes Podcast, Episode 247: My Senate Appearance on the Bill That Could Lead to Canada-Wide Blocking of X, Reddit and ChatGPT
The Law Bytes Podcast, Episode 246: Mohamed Zohiri on the Rise and Emerging Regulation of Stablecoins
Senate Bill Would Grant Government Regulatory Power to Mandate Age Verification For Search, Social Media and AI Services Accompanied By Threat of Court Ordered Blocking of Lawful Content
Government Reverses on Bill C-2: Removes Lawful Access Warrantless Demand Powers in New Border Bill
Why The Recent TikTok Privacy Ruling Swaps Privacy for Increased Surveillance

And educational institutions subscribe to Elsevier ScienceDirect
1. Publish a fake journal with Elsevier and the like
2. Make educational institurions subscribe to Elsevier and the like
3. Tie university professors with Big Pharma
4. PROFIT!
Regarding [3], visit http://www.ahrp.org/cms/content/view/523/9/
Harvard Medical Students Rebel Against Big Pharma
“The students say they worry that pharmaceutical industry scandals in recent years – including some criminal convictions, billions of dollars in fines, proof of bias in research and publishing and false marketing claims – have cast a bad light on the medical profession. And they criticize Harvard as being less vigilant than other leading medical schools in monitoring potential financial conflicts by faculty members.”
Marketing material, yes, but…
The info that the publication was paid for by Merck could be inferred, if you took the time. In the item pointed to, the ONLY advertisements were from Merck (at least that was the only ones that I noticed).
However, I’d agree that it should have been specifically mentioned. Sort of like the “Medi-Facts” commercials airing these days.